The most common adverse reactions based on clinical trial data (nausea, diarrhea, reduced appetite) are generally manageable
Whether you are currently taking semaglutide or tirzepatide , considering starting a protocol, or just trying to understand the shifting landscape around GLP-1 access, everything you need to know is here
How GLP-1 affects the microbiome GLP-1 RAs appear to shift the gut microbial ecosystem in favorable ways
But some companies are selling compound drugs with imported active pharmaceutical ingredients from plants that arent inspected or assessed by the FDA, per a page on the agencys website that was last updated Feb
doi: 10.1186/s13075-019-1810-5
The honest version: the strong, well-supported explanation is delayed gastric emptying causing food to sit and break down